Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of cost gouging, mentioning the stark distinction amongst U.S. selling prices and those in Europe and copyright.Novo Nordisk A/S can be a Danish multinational pharmaceutical company headquartered in Bagsværd,[